EP
MYO icon

Eversept Partners’s Myomo MYO Stock Holding History

Eversept Partners’s Portfolio MYO Stock Details MYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-150,000
Closed -$1.03M – 101
2021
Q4 		$1.03M Hold
150,000
– – 0.07% 88
2021
Q3 		$1.78M Buy
+150,000
New +$1.49M 0.12% 80

Other funds holding MYO

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
MAM
Must Asset Management Seoul, South Korea $40.9M AUM 22.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Eversept Partners's MYO Position: Q1 2022 in Review

Eversept Partners sold out of Myomo (MYO) in Q1 2022, closing a stake of 150,000 shares — an estimated $1.03M sold.

Eversept Partners first reported a position in MYO in Q3 2021 and held it in 2 quarters. The position peaked at $1.78M in Q3 2021. 22 funds tracked by Wall St. Rank hold MYO as of Q1 2022.

  • Eversept Partners reported no remaining Myomo position as of Q1 2022 after selling out during the quarter.
  • Eversept Partners sold 150,000 Myomo shares in Q1 2022, an estimated $1.03M.
  • Eversept Partners first reported a position in Myomo in Q3 2021 and held it in 2 quarters.
  • Eversept Partners's Myomo position peaked at $1.78M in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Myomo as of Q1 2022.

Based on Eversept Partners's 13F filing for Q1 2022, filed 16 May 2022.